Palisade Bio Files 2024 10-K
Ticker: PALI · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 10-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, biotech, stock-compensation
TL;DR
Palisade Bio's 2024 10-K is in, check out their stock and comp details.
AI Summary
Palisade Bio, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its operations and financial condition. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is involved in the biological products sector. The filing details various financial instruments and stock-based compensation plans, including restricted stock units and performance shares, relevant to its 2023 and 2024 fiscal periods.
Why It Matters
This filing provides investors with a comprehensive overview of Palisade Bio's financial health and strategic direction for the past fiscal year, including details on stock performance and compensation. It is crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Palisade Bio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-24 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- PALISADE BIO, INC. (company) — Filer
- Seneca Biopharma, Inc. (company) — Former company name
- Neuralstem, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-24 (date) — Filing date
- CARLSBAD, CA (location) — Business address
FAQ
What was Palisade Bio, Inc.'s primary business activity during the fiscal year ending December 31, 2024?
Palisade Bio, Inc. is engaged in the biological products sector, specifically focusing on biological products (no diagnostic substances) as indicated by its SIC code [2836].
What were the former names of Palisade Bio, Inc. and when did these name changes occur?
Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. (name change on 2020-01-27) and prior to that, Neuralstem, Inc. (name change on 2006-03-24).
What is the business address and phone number for Palisade Bio, Inc.?
The business address is 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009, and the business phone number is (858) 704-4900.
What types of stock-based compensation awards are mentioned in the filing for the fiscal year 2024?
The filing mentions awards related to us-gaap:RestrictedStockUnitsRSUMember, pali:The2021PlanMember, us-gaap:PerformanceSharesMember, us-gaap:ShareBasedCompensationAwardTrancheOneMember, and pali:TimeBasedRestrictedStockUnitsMember for the period of 2024-01-01 to 2024-12-31.
What financial instruments or agreements are specifically noted for the fiscal year 2024?
The filing notes pali:InsuranceFinancingArrangementMember as of 2023-12-31 and pali:WarrantInducementAgreementsMember for the period of 2024-01-01 to 2024-12-31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding PALISADE BIO, INC. (PALI).